Primary prophylaxis and treatment of venous thromboembolism in malignancy with focus on lung cancer: a review of current evidence
Pharmacotherapy for prevention of CAT in lung cancer must be individualized. DOACs have emerged as a practical and effective alternative to LMWH for both primary and secondary VTE prophylaxis after assessing risk-benefit.
Authors
- Danielle Lacava Voltani
- Cristhiam M. Rojas-Hernandez
- Felipe Guimaraes Pinto
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Pontifícia Universidade Católica de São Paulo (BR)
Publication Details
- Journal
- Current Opinion in Pulmonary Medicine
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1097/mcp.0000000000001265
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00